You can watch GNCA and buy or sell other stocks, options, and ETFs commission-free!
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.
William D. Clark
52 Week high
52 Week low